Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rex Fang & Innovation Equity Premium Income ETF (FEPI) vs Mesoblast Limited (MESO) Price & Performance

Rex Fang & Innovation Equity Premium Income ETFTrade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Rex Fang & Innovation Equity Premium Income ETF vs Mesoblast Limited — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $41.87, while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Mesoblast Limited is trading nearer its 52-week high, Rex Fang & Innovation Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.

FEPIMESO
Sector
Income / Options OverlayTechnology
52-Week High
$49.54$20.96
52-Week Low
$37.98$12.88
Market Cap
$2.21B
Enterprise Value
$2.21B

Returns comparison

Trailing returns across standard periods

About Rex Fang & Innovation Equity Premium Income ETF

FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.

Read more on FEPI

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO